Effects of dietary arginine on inflammatory mediator and receptor of advanced glycation endproducts (RAGE) expression in rats with streptozotocin-induced type 2 diabetes

British Journal of Nutrition

Volumn 104, Issue 5, 2010, Pages 686-692

  Pai, Man Hui ^a   Huang, Kuan Hsun ^a   Wu, Ching Hsiang ^a   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arginine; C reactive protein; Fructosamine; Receptor of advanced glycation endproducts (RAGE) expression; Type 2 diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ARGININE; C REACTIVE PROTEIN; CASEIN; FRUCTOSAMINE; GLUCOSE; STREPTOZOCIN; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; AUTACOID; IMMUNOGLOBULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INFLAMMATION; LIVER; LUNG PARENCHYMA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; ANIMAL; BLOOD; DIET THERAPY; EXPERIMENTAL DIABETES MELLITUS; LUNG; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ARGININE; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; FRUCTOSAMINE; INFLAMMATION MEDIATORS; LIVER; LUNG; MALE; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC;

EID: 77956937315     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451000111X     Document Type: Article

References (38)

1. Department of Health, Taiwan (2008) Top 10 leading causes of death in Taiwan. www.doh.gov.tw (accessed June 2009).
2. Goh SY & Cooper ME (2008) Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93, 1143-1152.
3. Bierhaus A, Hofmann MA, Ziegler R, et al. (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 37, 586-600.
4. Bierhaus A, Humpert PM, Morcos M, et al. (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83, 876-886.
5. Hnia K, Gayraud J, Hugon G, et al. (2008) L-Arginine decreases inflammation and modulates the nuclear factor-kB/matrix metalloproteinase cascade in mdx muscle fibers. Am J Pathol 172, 1509-1519.
6. Nieves C Jr & Langkamp-Henken B (2002) Arginine and immunity: A unique perspective. Biomed Pharmacother 56, 471-482.
7. Gianotti L, Alexander JW, Pyles T, et al. (1993) Argininesupplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide. Ann Surg 217, 644-653.
8. Evoy D, Lieberman MD, Fahey TJ III, et al. (1998) Immunonutrition: The role of arginine. Nutrition 14, 611-617.
9. Casas-Rodera P, Gomez-Candela C, Benitez S, et al. (2008) Immunoenhanced enteral nutrition formulas in head and neck cancer surgery: A prospective, randomized clinical trial. Nutr Hosp 23, 105-110.
10. Martina V, Masha A, Gigliardi VR, et al. (2008) Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabet Care 31, 940-944.
11. Lucotti P, Setola E, Monti LD, et al. (2006) Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 291, E906-E912.
12. Masiello P, Broca C, Gross R, et al. (1998) Experimental NIDDM: Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47, 224-229.
13. Masiello P, Novelli M, Fierabracci V, et al. (1990) Protection by 3-aminobenzamide and nicotinamide against streptozotocin- induced β-cell toxicity in vivo and in vitro. Res Commun Chem Pathol Pharmacol 69, 17-32.
14. Yeh CL, Pai MH, Li CC, et al. (2009) Effect of arginine on angiogenesis induced by human colon cancer: In vitro and in vivo studies. J Nutr Biochem (Epublication ahead of print version 14 May 2009).
15. Shang HF, Wang YY, Lai YN, et al. (2004) Effects of arginine supplementation on mucosal immunity in rats with septic peritonitis. Clin Nutr 23, 561-569.
16. Chung HF, Lees H & Gutman SI (1988) Effect of nitroblue tetrazolium concentration on the fructosamine assay for quantifying glycated protein. Clin Chem 34, 2106-2111.
17. Libby P, Ridker PM & Maseri A (2002) Inflammation and atherosclerosis. Circulation 105, 1135-1143.
18. Liu CT, Chen KM, Lee SH, et al. (2005) Effect of supplemental L-arginine on the function of T lymphocytes and the formation of advanced glycosylated end products in rats with streptozotocin-induced diabetes. Nutrition 21, 615-623.
19. Servetnick DA, Bryant D, Wells-Knecht KJ, et al. (1996) L-Arginine inhibits in vitro nonenzymatic glycation and advanced glycosylated end product formation of human serum albumin. Amino Acids 11, 69-81.
20. Menzel EJ & Reihsner R (1996) Comparison of the effect of different inhibitors of the non-enzymatic glycation of rat tail tendons and bovine serum albumin. Ann Clin Biochem 33, 241-248.
21. Reyes AA, Karl IE, Kissane J, et al. (1993) L-Arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 4, 1039-1045.
22. Zhang L, Zalewski A, Liu Y, et al. (2003) Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108, 472-478.
23. Schmidt MI, Duncan BB, Sharrett AR, et al. (1999) Markers of inflammation and prediction of diabetes mellitus in adults (atherosclerosis risk in communities study): A cohort study. Lancet 353, 1649-1652.
24. Pradhan AD, Manson JE, Rifai N, et al. (2001) C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327-334.
25. Glowinska B, Urban M, Peczynska J, et al. (2005) Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54, 1020-1026.
26. Mirjana M, Silva D, Goran P, et al. (2009) The acute-phase protein a2-macroglobulin plays an important role in radioprotection in the rat. Shock 31, 607-614.
27. Sun H, Lu X, Wu S, et al. (2009) The effects of C-reactive protein, interleukin-6, and tumor necrosis factor-a in rat allograft adventitial inflammation and allograft arteriosclerosis. Transplant Proc 41, 3909-3912.
28. Jang Y, Lincoff AM, Plow EF, et al. (1994) Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24, 1591-1601.
29. Albelda SM, Smith CW & Ward PA (1994) Adhesion molecules and inflammatory injury. FASEB J 8, 504-512.
30. Matsukawa A, Hogaboam CM, Lukacs NW, et al. (1999) Endogenous monocyte chemoattractant protein-1 protect mice in a model of acute septic peritonitis: Cross-talk between MCP-1 and leukotriene B4. J Immunol 163, 6148-6154.
31. Calder PC (1997) n-3 Polyunsaturated fatty acids as pharmacologic agents: A fishy tale? Nutrition 13, 1002-1004.
32. Wells BJ, Mainous AG III & Everett CJ (2005) Association between dietary arginine and C-reactive protein. Nutrition 21, 125-130.
33. Roth E (2007) Immune and cell modulation by amino acids. Clin Nutr 26, 535-544.
34. Graham MR, Baker JS, Evans P, et al. (2007) Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolicandrogenic steroid users. Growth Horm IGF Res 17, 201-209.
35. Yan SF, Ramasamy R & Schmidt AM (2009) Receptor for AGE (RAGE) and its ligands cast into leading roles in diabetes and the inflammatory response. J Mol Med 87, 235-247.
36. Lin L, Park S & Lakatta EG (2009) RAGE signaling in inflammation and arterial aging. Front Biosci 14, 1403-1413.
37. Brett J, Schmidt AM, Yan SD, et al. (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143, 1699-1712.
38. Bucciarelli LG, Ananthakrishnan R, Hwang YC, et al. (2008) RAGE and modulation of ischemic injury in the diabetic myocardium. Diabetes 57, 1941-1951.